Equicord

Us

Veterinary Advanced Therapies

Our History

We are national leaders in advanced veterinary therapies

EquiCord was born in 2012 in the hands of a multidisciplinary team formed up of veterinarians, biologists, engineers and pharmacists.

After positioning ourselves as national leaders in advanced veterinary therapies, we decided to take the leap into the European pharmaceutical industry by conducting various safety / efficacy clinical trials and building pioneering GMP facilities in the veterinary biotechnology sector.

After years of research, in 2019 we received the first European license for a drug based on Equine Umbilical Cord Mesenchymal Stem Cells (EUC-MSCs): HorStem®

Our Mission

At EquiCord we seek the development of new drugs that improve the quality of life of patients without ever forgetting to apply the maximum scientific rigor to our developments.

Our technology

EquiCord has developed a manufacturing process that allows obtaining high quality cells from a tissue such as the equine umbilical cord, which allows obtaining cells in a non-invasive way, prioriticing animal welfare.

Obtaining umbilical cord cells represents a competitive advantage over other sources of stem cells; with a younger starting material, greater proliferation capacity and greater safety compared to other sources such as adipose tissue, bone marrow or peripheral blood.

Our Facilities

EquiCord’s laboratories have been specifically designed for the manufacture of HorStem, seeking the optimisation of industrial processes and the highest quality of our products. Moreover, we also have a quality control laboratory in our own facilities that allow us to carry out the quality controls following the highest European standards.

Team

Iñigo Lusarreta

Chief Executive Officer

Industrial Engineer. Extensive experience in industrial companies.

Almudena Pradera

Chief Scientific Officer & Business Development

Doctor in Veterinary Medicine (DVM), Masters in Research and Development of medicines, PhD in physiology & pharmacology.

Miguel Rico

Quality Control Manager

Bachelor degree in Biology, PhD in Biology.

María García

Production Manager & Regulatory Affairs Associate

Bachelor degree in Biology, Masters in Cell Therapies Targets MCs.

Eva Punzón

Clinical Research Associated

Bachelor degree in Biology & Masters in Pharmacological Research.

Carlos García-Navas

Qualified Person & Quality Assurances

Bachelor degree in Pharmacists, Masters in pharma industry.

Marisol Muñoz

Purchase and logistic Manager

Deputy Executive

Iñigo Lusarreta

Chief Executive Officer

Industrial Engineer. Deep experience in industrial companies

Almudena Pradera

Chief Scientific Officer & Business Development

Doctor in Veterinary Medicine (DVM), Masters in Research and Development of medicines, PhD in physiology & pharmacology.

María García

Production Manager & Regulatory Affairs Associate

Bachelor degree in Biology, Masters in Cell Therapies Targets MCs.

Carlos García-Navas

Qualified Person & Quality Assurances

Bachelor degree in Pharmacists, Masters in pharma industry.

Miguel Rico

Quality Control Manager

Bachelor degree in Biology, PhD in Biology.

Eva Punzón

Clinical Research Associated

Bachelor degree in Biology & Masters in Pharmacological Research

Marisol Muñoz

Purchase and logistic Manager

Deputy Executive